Jay Lieberman | VP of Clinical Development
Meissa Vaccines

Jay Lieberman, VP of Clinical Development, Meissa Vaccines

Jay M. Lieberman, MD is Vice President of Clinical Development at Meissa Vaccines. Before joining Meissa, he was a Director of Medical Affairs at ICON plc (formerly PRA Health Sciences), where he served as a Medical Monitor and Therapeutic Expert for clinical trials of a variety of vaccines and infectious disease therapies in children and adults. Previously, Jay was a Regional Medical Director for Merck Vaccines. Before that, he was Medical Director of Infectious Diseases at Quest Diagnostics and Laboratory Director for Focus Diagnostics, an infectious diseases reference laboratory owned by Quest. Jay is a graduate of Princeton University and the New York University School of Medicine. He is a specialist in pediatric infectious diseases, having completed his residency training in pediatrics at Children’s Hospital of Los Angeles (CHLA) and fellowship training in pediatric infectious diseases at CHLA and at Harbor-UCLA Medical Center. He served as professor of clinical pediatrics at the University of California, Irvine (UCI) and chief of infectious diseases at Miller Children’s Hospital in Long Beach. While there, his clinical research activities included the evaluation of vaccines, other biologics, and antimicrobials in children, and he was honored to be a seven-time recipient of the Golden Apple Teaching Award from the UCI School of Medicine and a four-time recipient of the Faculty Teaching Award from Miller Children’s Hospital.


Day 2 - November 29 @ 12:20

Clinical development of an intranasal live attenuated RSV vaccine for infants

last published: 02/Jan/24 12:15 GMT

back to speakers